Dorchester Wealth Management CO Aeterna Zentaris Inc. Transaction History

Dorchester Wealth Management CO

  • $560 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 20, 2021
SELL
$0.51 - $3.34 $5,100 - $33,400
-10,000 Closed
0 $0
Q3 2020

Oct 19, 2020
BUY
$0.34 - $0.55 $3,400 - $5,500
10,000 New
10,000 $4,000

About Aeterna Zentaris Inc.

AEZS Quotes by TradingView
  • Ticker AEZS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 4,855,880
  • Market Cap $19.4M
  • Description
  • Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...
More about AEZS
Track This Portfolio

Track Dorchester Wealth Management CO Portfolio

Follow Dorchester Wealth Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dorchester Wealth Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Dorchester Wealth Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email